STROMUSC Testosterone Undecanoate 300mg/ml For Bodybuilding CAS:5949-44-0

   What It Is: Molecular Distinction

    Testosterone Undecanoate is not simply "testosterone." It's testosterone chemically bound to an undecanoic acid ester. This esterification profoundly alters its behavior:

    ●Lipophilic Tail: The undecanoate ester consists of an 11-carbon fatty acid chain. This highly lipophilic (fat-loving) structure makes TU extremely soluble in oil-based carriers but very slow to dissolve in aqueous environments like blood plasma.

    ●Prohormone Status: Injected TU is inactive. It acts as a prohormone, requiring enzymatic cleavage (hydrolysis) by esterases in the bloodstream and tissues to release the active free testosterone molecule.

    ●Ultra-Long Ester: The length and lipophilicity of the undecanoate ester make it the longest-acting commercially available testosterone ester. This defines all its subsequent characteristics and applications.

    The ester's properties translate into distinct features:

    ●Exceptionally Prolonged Half-Life: This is TU's hallmark. While often cited around 20-30 days for single-dose pharmacokinetics, its effective half-life in a multi-dose regimen (like bodybuilding) is significantly longer due to accumulation – realistically 16 weeks (approx. 112 days) or more to reach steady-state levels and for levels to significantly decline after cessation. This dwarfs enanthate (4-5 days) or cypionate (5-7 days).

    ●Gradual Release Profile: TU provides a remarkably stable and sustained elevation in serum testosterone levels. The peak is much lower and occurs later (around 7-10 days post-injection) compared to shorter esters, and the decline is extremely gradual over weeks and months.

    ●Infrequent Dosing: Due to the prolonged release, injections are required far less frequently than other esters – typically every 10-14 days at minimum in bodybuilding contexts, compared to weekly or multiple times per week.

    ●High Concentration Formulation: The 250mg/ml concentration (and higher in some preparations like Nebido at 1000mg/4ml) is necessary because the slow release means each injection delivers a large total payload over an extended period. This necessitates significant injection volumes.

    ●Minimal Peak/Trough Fluctuation: The ultra-slow release minimizes the dramatic spikes and drops in hormone levels associated with short esters, potentially leading to fewer estrogenic side effects per mg of testosterone delivered and a more consistent anabolic environment.

    Bodybuilders utilize TU's unique profile for specific goals:

    ●Cruising / Hormone Replacement Therapy (HRT) Blur: The primary bodybuilding application is during the "cruise" phase between intense "blast" cycles. Its stable levels provide a physiological testosterone baseline, allowing recovery of the HPTA sensitivity to some degree (though full recovery is unlikely without cessation) and mitigating the harsh crash when coming off shorter esters. It essentially provides a smoother transition to a maintenance dose.

    ●Long-Duration "Blasts" (Less Common): While not ideal for rapid mass gain phases due to its slow build-up, TU can be used as the base testosterone in very long cycles (6+ months). The stability minimizes side effect management fluctuations. However, reaching supraphysiological levels quickly requires a significant front-load or pairing with a faster ester initially.

    ●Reducing Injection Frequency: For individuals averse to frequent injections, TU offers a solution, requiring shots only every 10-14 days or sometimes longer depending on the dose, compared to multiple injections per week with propionate.

    ●Potentially Smoother Estrogen Management: The lack of sharp peaks can lead to less dramatic spikes in estrogen conversion (aromatization) compared to large boluses of short esters. However, the total estrogen load over time is still significant and requires management via Aromatase Inhibitors (AIs).

    Leveraging TU correctly offers specific advantages:

    ●Stable Hormonal Environment: Provides consistent anabolic signaling and mood, avoiding the highs and lows of short esters. This consistency is beneficial for both physical progress and psychological well-being.

    ●Reduced Injection Burden: Fewer injections mean less scar tissue buildup, reduced risk of infection per administration, and greater convenience.

    ●Potentially Milder Estrogenic Side Effects (Relative): While estrogen conversion still occurs, the absence of massive spikes may lead to less severe acne or water retention at comparable weekly doses compared to frequent short-ester injections. This is dose-dependent.

    ●Smoother Transition Off-Cycle: When ending a blast that included shorter esters and transitioning to a TU cruise or coming off completely, the gradual decline of TU levels prevents the abrupt crash in testosterone, potentially making Post Cycle Therapy (PCT) initiation smoother (though PCT timing is critical due to the long half-life).

    ●Long-Term Base for TRT-Style Use: For those committed to long-term androgen use, its stability mimics therapeutic TRT protocols.

    ●Cruise Dosage: Typically ranges from 125mg to 250mg every 10-14 days. This aims to maintain serum testosterone within or slightly above the physiological range (e.g., 700-1100 ng/dL). 125mg every 10 days is a common starting point.

    ●"Blast" Dosage (As Base): When used in a growth phase, doses range from 250mg to 500mg every 10-14 days. Higher doses significantly increase side effect risks and injection volume. Front-loading (e.g., 500mg first dose) or pairing with a faster ester (e.g., 200mg Test Propionate weekly for the first 3-4 weeks) is often employed to reach effective levels faster.

    ●Injection Protocol:

    ○Deep Intramuscular (IM) Only: Due to the high concentration and volume, gluteal (ventrogluteal or dorsogluteal) or quadriceps injections are standard. Subcutaneous (SubQ) is generally not recommended due to volume and potential for irritation/nodules.

    ○Large Volume: A 250mg dose requires 1ml of oil. 500mg requires 2ml. This necessitates using appropriately sized syringes (3ml) and needles (23g or 25g, 1-1.5 inch).

    ○Slow Injection: Injecting 1-2ml of thick oil should be done slowly to minimize discomfort and tissue trauma.

    ○Site Rotation: Crucial to prevent excessive scar tissue. Rotate between multiple large muscle groups.

    ○Warming Vial: Warming the vial slightly (e.g., in hands) can thin the oil, making drawing and injecting easier.

    ●Cruise Phase: Typically follows a blast phase using shorter-acting compounds. Duration is often 8-16 weeks or longer, depending on individual recovery goals and overall cycle planning. Dose: 125-250mg every 10-14 days. The goal is recovery and maintenance.

    ●Long Blast (TU as Base):

    ○Duration: Minimum 16 weeks, often 20-24+ weeks. Takes significant time to reach peak levels and capitalize on the stability.

    ○Structure: Often includes:

    ◇Weeks 1-4: "Kickstart" with a faster-acting oral (e.g., Dianabol 30mg/day) or injectable (e.g., NPP 400mg/week) + possibly a small front-load of TU (e.g., 500mg) or inclusion of Test Prop (200mg/week).

    ◇Weeks 1-24+: Testosterone Undecanoate (250-500mg every 10-14 days).

    ◇Weeks 1-16/20: A primary injectable anabolic (e.g., Deca-Durabolin, Equipoise, Masteron) at moderate-high doses.

    ◇Weeks 16/20-24+: Potentially transition to a drier compound (e.g., Masteron, Primobolan) or adjust AI as goals shift.

    ○AI & Support: Aromatase Inhibitor (e.g., Arimidex, Aromasin) on hand and used based on blood work and symptoms. Liver support (if using orals), cardiovascular support (e.g., fish oil, CoQ10), and potentially HCG during the blast (250-500 IU 2x/week) are common.

    ●Cruise Phase: Follows the blast, back to TRT-level TU dosing.

    ●True Half-Life Complexity: While often simplified to "20-30 days," TU's pharmacokinetics are complex. Its terminal elimination half-life is indeed long (approx. 20-34 days after reaching steady-state), but its effective half-life in a multi-dose regimen is vastly longer due to accumulation. It takes approximately 16 weeks (112 days) of regular dosing to reach steady-state concentrations. Similarly, after the last injection, it takes many months (4-6+ months) for serum levels to drop sufficiently low (< 50 ng/dL) to even consider starting PCT meaningfully. This is its most critical characteristic impacting PCT strategy.

    ●Accumulation is Key: Each injection adds to the total circulating testosterone load, which decays extremely slowly. Missing a dose has minimal immediate impact.

    PCT after a cycle involving Testosterone Undecanoate, especially as the primary or last compound, is uniquely challenging and requires immense patience:

    ●The Waiting Game is Paramount: DO NOT start PCT until serum testosterone is confirmed LOW (< 50 ng/dL) via blood work. Starting PCT (SERMs like Clomid/Nolvadex) while exogenous testosterone levels are still significantly elevated is futile and potentially counterproductive. This typically means waiting 4-6 months AFTER the last TU injection. Attempting PCT earlier wastes medication and delays true recovery.

    ●HCG Role: HCG is often used during the blast and potentially the cruise phase to maintain testicular function. Its use before PCT (the typical "blast" of HCG) is largely ineffective with TU still active due to the overwhelming exogenous testosterone suppressing the HPTA regardless. Some may use low-dose HCG during the long waiting period, but its benefit is debated.

    ●Standard PCT Protocol (ONCE LEVELS ARE LOW):

    ○Week 1-4: Clomid (Clomiphene Citrate) 50mg daily OR Nolvadex (Tamoxifen Citrate) 40mg daily.

    ○Week 5-8: Clomid 25mg daily OR Nolvadex 20mg daily.

    ●Blood Work is Non-Negotiable: Crucial before starting PCT (confirm low T, baseline LH/FSH), mid-PCT, and 6-8 weeks post-PCT to assess recovery success (LH/FSH in normal range, testosterone recovering).

    ●Realistic Expectations: Full HPTA recovery after long-term steroid use, especially with ultra-long esters like TU, is difficult and uncertain. Many users planning PCT opt for shorter esters for their final compound to reduce the waiting time significantly (e.g., switching to Propionate for the last 4-6 weeks).

Brand	STROMUSC
Trade names	Oral: Kyzatrex, Andriol, Jatenzo IM: Aveed, Nebido TU; Testosterone undecylate; CLR-610 Testosterone 17β-undecanoate; ORG-538;
CAS	5949-44-0
Molar mass	456.711
Formula	C30H48O3
Purity	Above 98%
Apprarance	300mg/ml, 10ml/bottle

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

    Testosterone Undecanoate 250 is not a mass-building "rocket fuel." It's a slow-burning, long-duration engine best suited for specific bodybuilding applications: providing stable physiological levels during cruise phases or acting as the ultra-stable foundation for exceptionally long bulking cycles. Its defining feature – the extraordinarily long half-life and accumulation – demands a paradigm shift in cycle planning and, critically, in Post Cycle Therapy strategy. The convenience of infrequent injections comes with the significant responsibility of understanding and respecting its prolonged pharmacokinetics. Impatience in starting PCT after TU use is a guaranteed path to failure. It requires meticulous planning, rigorous blood work, and above all, immense patience. Used strategically by informed individuals, it offers a unique profile of hormonal stability unmatched by other testosterone esters. Used carelessly, particularly regarding PCT timing, it can lead to extended periods of suppression and hinder recovery.

Hot Tags: stromusc testosterone undecanoate 300mg/ml for bodybuilding cas:5949-44-0, China stromusc testosterone undecanoate 300mg/ml for bodybuilding cas:5949-44-0 manufacturers, suppliers, factory